Status:
UNKNOWN
The Effect of Interscalene Block on Intracranial Pressure
Lead Sponsor:
Cumhuriyet University
Conditions:
Brachial Plexus Block
Intracranial Pressure Increase
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The study aims to show the effects of interscalene brachial plexus (ISBP) block on intracranial pressure by measuring optic nerve sheath diameter (ONSD) and internal vein collapsibility index (IJV-CI)...
Detailed Description
40 is the targeted number of patients who are going to have humerus fracture or opened rotator-cuff surgery. Single shot-ISBP block with 25 ml local anesthetic will be performed as anesthetic approach...
Eligibility Criteria
Inclusion
- Patients who had elective humeral fracture and open rotator-cuff surgery,
- Patients aged 18-85 years,
- Patients have ASA I-II anesthesia risk according to the American Society of Anesthesiologists (ASA) risk classification,
- Patients that gave consent for participation in the study will be included.
Exclusion
- Patients who do not give consent to the study,
- Patients with infection and open wounds in the area of skin puncture and eyelids,
- Patients have any history of intracranial pathology,
- Patients have nerve blockade contraindications such as coagulation disorder and antithrombotic-anticoagulant use,
- Patients have a history of allergy to one of the study drugs,
- Patients have a body mass index over 35 kg/m2,
- Patients with contralateral pneumothorax,
- Patients with severe respiratory distress,
- Patients with uncontrolled hypertension,
- Patients with acute or chronic eye disease,
- Patients with previous eye surgery,
- Patients using a beta-blocker known to increase intraocular pressure,
- Patients using calcium channel blockers, statins and nitrates,
- Patients in need of intraoperative sedation,
- Patients who develope any complications (hoarseness, horner's syndrome, respiratory distress, local anesthetic toxicity) due to ISBP block will be excluded from the study.
Key Trial Info
Start Date :
February 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05434975
Start Date
February 25 2022
End Date
September 15 2022
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sivas Cumhuriyet University
Sivas, Turkey (Türkiye), 58000